Recent Brain Cancer News

First In Class Immunostimulating Anticancer Agent able to Directly Inhibit Tumor Signaling and Kill Tumor Cells, is in Clinical Trial for Glioblastoma and Melanoma Metastatic to the Brain

(September 13, 2018)

Small molecule lead drug candidate blocks a critical target for tumors and crosses the blood brain barrier; begins first brain cancer patient dosing in clinical trial at MD Anderson Cancer Center HOUSTON,... Continue Reading


Engineering the Common Cold Virus Appears to be Promising Treatment Approach for Some Brain Tumors

(July 6, 2018)

A “smart bomb” oncolytic adenovirus appears to induce dramatic responses with long-term survival in recurrent high-grade gliomas, according to the early results of a study published in The... Continue Reading


Interim Survival Data from Phase 3 Trial of DCVax®-L for Glioblastoma Reported

(May 30, 2018)

Northwest Biotherapeutics, developer of DCVax® personalized immune therapies for solid tumor cancers, announced today the publication of interim blinded survival data from its Phase 3 clinical trial... Continue Reading


Interim Results from Clinical Trial of Immunotherapy for Glioblastoma Show Significant Clinical Benefit

(May 29, 2018)

The research team behind an emerging immunotherapy for cancer will present interim findings from an ongoing clinical study in patients with brain cancer at a major research meeting next month. Collaborators... Continue Reading